HIF-1α Inhibition Improves Anti-Tumor Immunity and Promotes the Efficacy of Stereotactic Ablative Radiotherapy (SABR)

SIMPLE SUMMARY: Stereotactic ablative radiotherapy (SABR), which irradiates tumors with high-dose radiation per fraction, promotes anti-tumor immunity by stimulating various immune processes. SABR also induces vascular damage and obstructs blood flow, thereby increasing tumor hypoxia and upregulatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Song, Chang W., Kim, Hyunkyung, Cho, Haeun, Kim, Mi-Sook, Paek, Sun-Ha, Park, Heon-Joo, Griffin, Robert J., Terezakis, Stephanie, Cho, Lawrence Chinsoo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265101/
https://www.ncbi.nlm.nih.gov/pubmed/35805044
http://dx.doi.org/10.3390/cancers14133273

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9265101/
https://www.ncbi.nlm.nih.gov/pubmed/35805044
http://dx.doi.org/10.3390/cancers14133273

Ejemplares similares